Overview of Dr. Pua
Dr. Bradley Pua is a radiologist in New York, NY and is affiliated with NewYork-Presbyterian/Weill Cornell. He received his medical degree from NYU School of Medicine and has been in practice 14 years. He specializes in vascular & interventional radiology.
Office
525 E 68th Street
New York, NY 10065Fax+1 646-962-0941
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Radiology-Diagnostic, 2007 - 2011
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Vascular and Interventional Radiology, 2006 - 2007
- NYU Grossman School of MedicineResidency, Surgery, 2003 - 2006
- New York University School of MedicineClass of 2003
Certifications & Licensure
- NY State Medical License 2006 - 2025
- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Start of enrollment: 2009 Nov 01
- Study of Cryoablation for Metastatic Lung Tumors Start of enrollment: 2014 Apr 10
- NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung Start of enrollment: 2018 Jun 29
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsInterventional radiology fellowship website content: what is the relevance to potential applicants?Resmi A. Charalel, Bradley B. Pua, Naveen Galla, Samir K. Trehan, David C. Madoff
Clinical Imaging. 2016-11-01 - 104 citationsPercutaneous lung biopsy: technique, efficacy, and complications.Ronald S. Winokur, Bradley B. Pua, Brian W. Sullivan, David C. Madoff
Seminars in Interventional Radiology. 2013-06-01 - 44 citationsQuality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis.Attract Trial Investigators
Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2020-01-01
Press Mentions
- Federal Task Force Expands Screening Recommendations to Include Current and Former Smokers Ages 50-80March 9th, 2021
- PharmaCyte Biotech Completes Medical Manual for IND FilingMay 4th, 2020
- Schedule at A GlanceJune 8th, 2015
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: